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Abstract: Neutropenic sepsis is a common clinical entity occurring in postchemotherapy 
patients. Infection may not be the cause of fever in such patients after neutrophil-count recov-
ery. Herein, we present two patients who developed fever during the neutropenic phase of 
induction chemotherapy and were treated with broad-spectrum antibiotics until they were no 
longer febrile and had recovered their neutrophil count. Being off antibiotics, they redeveloped 
fever within 48–72 hours. These fevers seemed to be secondary to postinfectious inflammatory 
response and not infection, supported by the fact that adequate antibiotic treatment was given 
and the collected fluid contained neutrophils but the cultures were negative. We hypothesize an 
explanation for this phenomenon based on the “homing of neutrophils” to bone marrow, which 
involves chemoattraction of CXC chemokine receptor (CXCR)-4 expressed on neutrophils 
towards the chemokine stromal cell-derived factor (SDF)-1 (CXCL12) expressed constitutively 
by bone marrow. Literature has shown that elevation of SDF-1 levels at injured/inflamed sites 
might create a similar gradient. This gradient results in the migration of neutrophils to the 
sites of previous injury/inflammation, leading to the formation of sterile abscesses. Based on 
our cases, we also conclude that antibiotics do not prevent the formation or treat such sterile 
“abscesses”; however, the drainage of these “abscesses” and treatment with anti-inflammatory 
agents are useful in such cases.
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Introduction
Neutrophils are one of the first cells arriving at the site of infection, and play an impor-
tant role in combating an invading pathogen.1 Neutrophils express CXC chemokine 
receptor (CXCR)-4 on their cell surface,2,3 whose expression is upregulated during 
maturation.3,4 As they mature, the upregulation of CXCR4 receptors enables them to 
migrate down the concentration gradient of stromal cell-derived factor (SDF)-1. This 
chemoattraction of CXCR4 receptors to SDF-1 forms a CXCR4/CXCL12 axis.3,4 
Bone marrow, for example, expresses SDF-1 constitutively.2,3 Thus, during homing of 
neutrophils to bone marrow, they migrate towards SDF-1 expressed by bone marrow, 
forming an important mechanism for neutrophil homing to bone marrow.2,3 The litera-
ture documents elevated SDF-1 levels at the sites of injury/inflammation in lungs,5,6 
intestine,7,8 synovial fluid,7,9 brain,10–12 kidney,13 heart,14 and liver.15 This increase of 
SDF-1 in such sites leads to chemotaxis of neutrophils to sites of injury/inflamma-
tion, sometimes leading to unwanted sequelae. Herein, we present two cases with 
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adequately treated localized infectious foci while neutropenic 
secondary to induction chemotherapy, who 48–72 hours 
after neutrophil recovery developed systemic inflammatory 
response syndrome (SIRS) with aseptic inflammatory col-
lections in the same region of previous inflammatory foci. 
We also provide an explanation for this phenomenon based 
on neutrophil homing to areas of prior inflammation pos-
sibly driven by CXCR4 and SDF-1 interaction, and use this 
knowledge in proposing treatment recommendations for such 
inflammatory responses.
Case presentation
A 32-year-old woman with remote history of pilonidal abscess 
presented with easy bruising, fatigue, generalized bony pain, 
and heavy menses. She was found to have acute myeloid 
leukemia (AML) with 34% bone marrow blasts and t(8;21)
(q22;q22). She was placed on levaquin, acyclovir, and posa-
conazole for prophylaxis, and induction chemotherapy with 
standard daunorubicin and cytarabine was initiated for a total 
of 7 days. While neutropenic, she developed an area of tender-
ness and erythema around her sacrum in the previous site of 
a pilonidal cyst and then became febrile. Cefepime was initi-
ated, and was later changed to vancomycin and piperacillin/ 
tazobactam because of suspected rash from cefepime. She 
remained febrile for 3 days after initiating antibiotic therapy. 
Blood cultures were drawn and remained negative.  Computed 
tomography (CT) of the pelvis revealed ill-defined soft-tissue 
thickening in the mid-lower back from the lumbar spine to 
the sacrum within the deep subcutaneous fat to the gluteal 
crease without any evidence of muscular involvement. 
There was also a well-defined fluid collection measuring 
approximately 2.9 × 0.8 cm within the subcutaneous tissues, 
superficial to the lower sacrum and to the right of the midline 
(Figure 1A). Erythema and fever resolved, and tenderness 
improved with antibiotics. Vancomycin was discontinued 
after 48 hours, but piperacillin/tazobactam was continued until 
her neutrophil count became .500 neutrophils/µL. The total 
duration of antibiotic therapy was 11 days. A postinduction 
bone marrow evaluation revealed no residual leukemia.
After 48 hours off antibiotics, the presacral tenderness 
and redness returned. Examination revealed an area of fluctu-
ance, erythema, and tenderness in the same location of her 
previous pilonidal cystectomy. At this time, her absolute 
neutrophil count (ANC) was 2,500/µL. CT of the pelvis 
showed an increase in size of well-defined fluid collection, 
measuring 1.3 × 2.2 × 6.4 cm (Figure 1B). She was off 
antibiotics for 48–72 hours before aspiration, and drainage 
was performed. Foul, cloudy, purulent fluid was aspirated 
and sent for analysis. This showed many neutrophils with 
no organisms, and cultures were negative. The patient was 
placed on ertapenem, and her symptoms improved primar-
ily after initial drainage. Follow-up sonogram, done after 
3 days, showed a mild complex fluid collection within the 
subcutaneous tissues. She underwent incision and drainage of 
the area of greatest redness. Retrieved tissue and fluid were 
sent for cultures and remained negative again. Gram stain of 
the swabbed fluid showed rare neutrophils, and no organisms 
were seen. The area healed well, and after 12 days she pro-
ceeded with treatment for her AML with a matched-sibling 
donor stem cell transplant without complications.
The second case was a 52-year-old male patient who 
presented with pancytopenia, 35% myeloid blasts in the bone 
marrow, fever, chills, and tachycardia, with redness, swelling, 
and pain involving the medial posterior left thigh, and mild 
redness and swelling but no pain of the lateral aspect of the 
right thigh. Magnetic resonance imaging (MRI) of the left 
thigh showed pyomyositis with extensive edema throughout 
quadriceps musculature, with focal areas of myonecrosis and 
intercommunicating pockets of fluid. Creatine phosphokinase 
was 905 U/L. There was also subcutaneous edema sugges-
tive of cellulitis. He was diagnosed with AML and sepsis. 
 Peripheral blood, bone marrow, and urine cultures obtained 
initially showed no bacterial or fungal infection. He was 
started on vancomycin, cefepime, and clindamycin, and 
then changed to vancomycin and piperacillin/tazobactam 
after 8 days. AML induction therapy with daunorubicin 
and cytarabine was initiated for a total of 7 days. Surgical 
intervention was considered but not done, due to clinical 
improvement while on antibiotics.
With antibiotic therapy, the patient became afebrile with 
decreased pain, swelling, and redness of the left upper thigh 
and stabilization of the right thigh. On postinduction day 21, 
Figure 1 Pilonidal abscess, sagittal computed tomography (CT) images on 
admission (A) and time of neutrophil recovery (B). (A) CT scan showing soft-tissue 
ill-defined thickening from the lumbar spine to the sacrum, with a focal well-defined 
fluid collection measuring approximately 2.9 × 0.8 cm (arrow). (B) Three weeks 
postinduction CT sagittal images showing increase in well-defined fluid collection, 
now measuring 1.3 × 2.2 × 6.4 cm (marked with arrow).
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the ANC was 80/µL, and while on piperacillin/tazobactam, 
the patient developed fever. A repeat MRI showed progres-
sively evolving areas of myonecrosis/abscess in the left 
thigh, predominately in the abductor brevis and magnus, 
and unchanged to slightly decreased area of myonecrosis/
abscess in the proximal right thigh, with slightly increased 
enhancement and edema in the adductor magnus (Figure 2A). 
Orthopedic surgery was reconsidered, and it was thought that 
overall the abscesses were unchanged. Blood cultures were 
drawn and were negative. Slowly, his symptoms improved 
with antibiotics, and he was discharged off antibiotics after 
he became afebrile and had recovered his neutrophil count 
(ANC was 666/µL upon discontinuation of antibiotics).
Three days later, he presented with severe pain and 
increased swelling in his left thigh. His white blood cell count 
was 8,800/µL at that point. On examination, his left thigh 
was swollen and painful to the touch without any fluctuation. 
A repeat MRI showed marked progression and enlargement 
of multiple fluid collections in the left thigh consistent 
with worsening areas of myonecrosis/abscess (Figure 2B). 
Routine blood cultures and one fungal blood culture were 
obtained, and showed no growth. Prior to reinitiation of 
antibiotic therapy, a CT-guided aspiration was done and a 
drain placed. The recovered fluid showed no bacteria, fun-
gus, or mycobacteria. Gram stain, however, showed many 
neutrophils and red blood cells, but no organisms. Following 
the procedure, his left thigh pain improved; however, his 
pain dramatically improved with anti-inflammatory agents. 
Vancomycin and piperacillin/tazobactam were started, and 
later changed to ertapenem. The drain output slowed down 
and became insignificant 15 days post-drain placement. 
Ertapenem was stopped 20 days after drain placement. The 
patient remained afebrile and proceeded with subsequent 
chemotherapy.
Discussion
Migration of cells through the blood to the bone marrow 
niches requires active navigation, a process termed “homing.” 
Homing is thought to be a coordinated, multistep process 
that involves signaling bySDF-1 and its chemokine receptor 
CXCR4, as well as other chemokines.2–4 Homing is essential 
for bone marrow stem cell transplantation to be effective, but 
is also essential for successful host eradication of bacterial 
pathogens and survival in polymicrobial sepsis.16 The bone 
marrow acts as a reservoir for neutrophils, whose release 
and egress is tightly regulated.2,3 This interaction is very 
crucial during bacterial infection and sepsis, but is also very 
important in sterile inflammatory processes.
A sterile inflammatory process happens in times of 
vascular disruption, not from infection but from trauma, 
hypotension, myocardial infarction, cerebral vascular events, 
or arterial thrombus. With aggressive treatment measures, 
such as volume replacement, revascularization, or anti-
thrombotic  therapy, the tissue that was ischemic becomes 
perfused again. Reperfusion injury has been studied for more 
than 30 years, specifically in cerebral ischemia,10,17 drug-
induced hepatotoxicity,18 and ischemic cardiac disease.14 
Several studies have looked at the mechanism of neutrophil 
depletion16,18 to prevent reperfusion injury, while others have 
looked at ways to alter the signaling of the SDF-1/CXCR4 
axis.11,14,19
This has a direct correlation with the two cases presented, 
in which induction chemotherapy was given to two patients 
with localized inflammation. Postinduction, they developed 
fevers and localized infectious foci, which were appropri-
ately treated with antibiotics. The bone marrow reserves 
of neutrophils, progenitor stem cells, and myeloid blasts 
were dramatically reduced, because of the cytotoxic doses 
of chemotherapy. During this phase, these two patients had 
resolution of their symptoms because of appropriate use of 
antibiotics. Standard treatment is to discontinue all antibiotics 
after ANC is greater than 500/µL, provided there is resolu-
tion of fever and signs and symptoms of infection. In both 
instances, these two patients returned within 48–72 hours 
with ANC .2,500/µL, with worsened pain and an increased 
fluid collection. In both cases, no organism was found, but 
only abundant neutrophils were seen on Gram stain. Also, 
in the second case, the patient’s symptoms did not improve 
until anti-inflammatory agents were given.
One of the proposed hypotheses could be that these two 
patients had an infected abscess or leukemic infiltration 
within previous inflammatory sites when they developed 
fevers. This could have led to tissue ischemia or could have 
Figure 2 (A) Magnetic resonance imaging (MRI) T2 coronal images with marked 
edema and enhancement of the left adductor magnus and brevis muscles, with focal 
areas of nonenhancement consistent with myonecrosis (arrow). (B) MRI T1 fast-spin 
coronal images with progression of the edema and development of a fluid collection 
in the proximal medial thigh measuring 3.9 × 10.3 × 8.5 cm (marked with arrow).
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elicited inflammatory response leading to tissue injury. 
With this ischemia10–13 or inflammation,5–8 we hypothesize 
that there might have been increased levels of chemokines, 
specifically SDF-1, at these inflammatory sites. Antibiotics 
were given, and these areas were sterilized. As the bone 
marrow recovered, the young immature neutrophils, which 
are low in CXCR4 expression, started expressing CXCR4 as 
they matured.3,4 As they expressed CXCR4 on their surface, 
they acquired the ability to migrate towards elevated SDF-1 
levels at previous inflammatory sites.3,4 This insurgence of 
neutrophils into these areas could explain in our situation 
the inflammatory response with increased fluctuation and 
return of symptoms.
It is difficult to differentiate SIRS without infection from 
sepsis clinically.20,21 SIRS criteria are moderately associated 
with infection,22 and as mortality increases with delay in 
administration of antibiotics,23 most cases with SIRS end 
up being on antibiotics. In our case as well, antibiotics were 
initiated but later discontinued when cultures were negative. 
Though some studies suggest anti-inflammatory properties 
of some antibiotics like macrolides and newer-generation 
quinolones,24 there are no definitive data to show a rationale 
for using antibiotics in SIRS without infection. Also, in our 
second case, symptoms improved only after administration 
of nonsteroidal anti-inflammatory drugs (NSAIDs). Though 
some studies have shown efficacy of NSAIDs in SIRS with-
out infection,25 use of NSAIDs in postinfectious inflammatory 
response has not been studied.
In conclusion, we present two cases of a sterile inflamma-
tory collection developing at the time of neutrophil recovery 
from neutropenia at the site of adequately treated infection. 
We speculate that these sterile inflammatory collections 
were related to neutrophil recovery and homing to areas of 
prior injury/inflammation and not in response to an active 
infection.
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